Mutations of the SLX4 gene in Fanconi anemia (original) (raw)

Nature Genetics volume 43, pages 142–146 (2011)Cite this article

Subjects

Abstract

Fanconi anemia is a rare recessive disorder characterized by genome instability, congenital malformations, progressive bone marrow failure and predisposition to hematologic malignancies and solid tumors1. At the cellular level, hypersensitivity to DNA interstrand crosslinks is the defining feature in Fanconi anemia2. Mutations in thirteen distinct Fanconi anemia genes3 have been shown to interfere with the DNA-replication–dependent repair of lesions involving crosslinked DNA at stalled replication forks4. Depletion of SLX4, which interacts with multiple nucleases and has been recently identified as a Holliday junction resolvase5,6,7, results in increased sensitivity of the cells to DNA crosslinking agents. Here we report the identification of biallelic SLX4 mutations in two individuals with typical clinical features of Fanconi anemia and show that the cellular defects in these individuals' cells are complemented by wildtype SLX4, demonstrating that biallelic mutations in SLX4 (renamed here as FANCP) cause a new subtype of Fanconi anemia, Fanconi anemia-P.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Figure 1: Characterization of cell lines from individuals with Fanconi anemia with SLX4 mutations.

The alternative text for this image may have been generated using AI.

Figure 2: SLX4 is defective in two individuals with Fanconi anemia.

The alternative text for this image may have been generated using AI.

Figure 3: Complementation of RA3083 and RA3331 cells with the SLX4 cDNA.

The alternative text for this image may have been generated using AI.

Figure 4: Interaction of mutant forms of SLX4 with its partners and with ubiquitin.

The alternative text for this image may have been generated using AI.

Similar content being viewed by others

Accession codes

Accessions

NCBI Reference Sequence

References

  1. Auerbach, A.D. Fanconi anemia and its diagnosis. Mutat. Res. 668, 4–10 (2009).
    Article CAS Google Scholar
  2. Auerbach, A.D. & Wolman, S.R. Susceptibility of Fanconi′s anaemia fibroblasts to chromosome damage by carcinogens. Nature 261, 494–496 (1976).
    Article CAS Google Scholar
  3. Moldovan, G.L. & D'Andrea, A.D. How the fanconi anemia pathway guards the genome. Annu. Rev. Genet. 43, 223–249 (2009).
    Article CAS Google Scholar
  4. Knipscheer, P. et al. The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. Science 326, 1698–1701 (2009).
    Article CAS Google Scholar
  5. Fekairi, S. et al. Human SLX4 is a Holliday junction resolvase subunit that binds multiple DNA repair/recombination endonucleases. Cell 138, 78–89 (2009).
    Article CAS Google Scholar
  6. Munoz, I.M. et al. Coordination of structure-specific nucleases by human SLX4/BTBD12 is required for DNA repair. Mol. Cell 35, 116–127 (2009).
    Article CAS Google Scholar
  7. Svendsen, J.M. et al. Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Cell 138, 63–77 (2009).
    Article CAS Google Scholar
  8. Ciccia, A., McDonald, N. & West, S.C. Structural and functional relationships of the XPF/MUS81 family of proteins. Annu. Rev. Biochem. 77, 259–287 (2008).
    Article CAS Google Scholar
  9. Garcia-Higuera, I. et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7, 249–262 (2001).
    Article CAS Google Scholar
  10. Smogorzewska, A. et al. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129, 289–301 (2007).
    Article CAS Google Scholar
  11. Kratz, K. et al. Deficiency of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to interstrand crosslinking agents. Cell 142, 77–88 (2010).
    Article CAS Google Scholar
  12. Liu, T., Ghosal, G., Yuan, J., Chen, J. & Huang, J. FAN1 acts with FANCI-FANCD2 to promote DNA interstrand cross-link repair. Science 329, 693–696 (2010).
    Article CAS Google Scholar
  13. MacKay, C. et al. Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2. Cell 142, 65–76 (2010).
    Article CAS Google Scholar
  14. Smogorzewska, A. et al. A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair. Mol. Cell 39, 36–47 (2010).
    Article CAS Google Scholar
  15. Vaz, F. et al. Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat. Genet. 42, 406–409 (2010).
    Article CAS Google Scholar
  16. Kutler, D.I. et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101, 1249–1256 (2003).
    Article CAS Google Scholar
  17. Hofmann, K. Ubiquitin-binding domains and their role in the DNA damage response. DNA Repair (Amst.) 8, 544–556 (2009).
    Article CAS Google Scholar
  18. Sobhian, B. et al. RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. Science 316, 1198–1202 (2007).
    Article CAS Google Scholar
  19. Howlett, N.G. et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297, 606–609 (2002).
    Article CAS Google Scholar
  20. Xia, B. et al. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat. Genet. 39, 159–161 (2007).
    Article CAS Google Scholar
  21. Meindl, A. et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat. Genet. 42, 410–414 (2010).
    Article CAS Google Scholar
  22. Rahman, N. et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat. Genet. 39, 165–167 (2007).
    Article CAS Google Scholar
  23. Seal, S. et al. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat. Genet. 38, 1239–1241 (2006).
    Article CAS Google Scholar
  24. Wooster, R. et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789–792 (1995).
    Article CAS Google Scholar
  25. Lamesch, P. et al. hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes. Genomics 89, 307–315 (2007).
    Article CAS Google Scholar
  26. Dolma, S., Lessnick, S.L., Hahn, W.C. & Stockwell, B.R. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3, 285–296 (2003).
    Article CAS Google Scholar

Download references

Acknowledgements

We are grateful to the affected individuals and their families for their participation in this study. We thank the Harper Lab, Harvard Medical School, Boston, Massachusetts, USA for reagents, E. Foley for advice and J. de Winter for communicating unpublished results. H.H. is supported by the Deutsche Forschungsgemeinschaft SPP1230, the Bundesministerium für Bildung und Forschung network for Bone Marrow failure Syndrome, and FoneFA. A.S. is supported by the Burroughs Wellcome Fund Career Award for Medical Scientists and is a Rita Allen Foundation and an Irma T. Hirschl Scholar.

Author information

Author notes

  1. Yonghwan Kim and Francis P Lach: These authors contributed equally to this work.

Authors and Affiliations

  1. Laboratory of Genome Maintenance, The Rockefeller University, New York, New York, USA
    Yonghwan Kim, Francis P Lach, Rohini Desetty & Agata Smogorzewska
  2. Division of Pediatric Hematology/Oncology, Herman B. Wells Center for Pediatric Research, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA
    Helmut Hanenberg
  3. Department of Otorhinolaryngology, Heinrich Heine University, Duesseldorf, Germany
    Helmut Hanenberg
  4. Human Genetics and Hematology, The Rockefeller University, New York, New York, USA
    Arleen D Auerbach

Authors

  1. Yonghwan Kim
  2. Francis P Lach
  3. Rohini Desetty
  4. Helmut Hanenberg
  5. Arleen D Auerbach
  6. Agata Smogorzewska

Contributions

The study was designed by A.S., Y.K. and F.P.L. Subject recruitment and sample collection was done by A.D.A., F.P.L. and A.S. Characterization with respect to Fanconi anemia subgroups was performed by A.S., F.P.L., H.H. and A.D.A. Mutation analysis and functional studies were performed by A.S., Y.K., F.P.L. and R.D. The manuscript was written by A.S. with help from other authors.

Corresponding author

Correspondence toAgata Smogorzewska.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

About this article

Cite this article

Kim, Y., Lach, F., Desetty, R. et al. Mutations of the SLX4 gene in Fanconi anemia.Nat Genet 43, 142–146 (2011). https://doi.org/10.1038/ng.750

Download citation

This article is cited by